<html>
<head>
<meta charset='utf-8'>
<title>Daily Biotech & Science Report (2025-10-14)</title>
<style>

             body { font-family: Arial, sans-serif; margin: 20px; background-color: #f4f4f4; }
             .container { max-width: 800px; margin: auto; background: #fff; padding: 20px; }
             h1, h2, h3 { color: #333; }
             .news-item, .paper-item { border: 1px solid #ddd; padding: 15px; margin-bottom: 15px; border-radius: 5px; background: #fafafa; }
             .source-date { font-size: 0.9em; color: #666; }
             a { color: #1a0dab; text-decoration: none; }
             a:hover { text-decoration: underline; }
         
</style>
</head>
<body>
<div class='container'>
<h1>Daily Biotech & Science Report (2025-10-14)</h1>
<h2>Biotech Industry & Market News</h2>
<div class='news-item'>
<h3>StockWatch: Novo Nordisk Raises MASH Bet with Up-to-$5.2B Akero Acquisition</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-10-14</em></p>
<p>Akero, based in South San Francisco, CA, brings to Novo Nordisk a Phase III fibroblast growth factor 21 (FGF21) analogue efruxifermin (EFX) that is now in Phase III studies for the treatment of moderate to advanced liver fibrosis (F2-F3) as well as for treatment of cirrhosis (F4). The post StockW...</p>
<p><a href='https://www.genengnews.com/topics/translational-medicine/stockwatch-novo-nordisk-raises-mash-bet-with-up-to-5-2b-akero-acquisition/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Cambridge’s biotech scene: The cornerstone of the UK’s Golden Triangle</h3>
<p class='source-date'><em>Labiotech.eu • 2025-10-13</em></p>
<p>Home to a well-established hub with strong investment and startup activity, discover what makes Cambridge's biotech scene so special. The post Cambridge’s biotech scene: The cornerstone of the UK’s Golden Triangle appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use a...</p>
<p><a href='https://www.labiotech.eu/in-depth/cambridge-biotech-hub/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Three big questions ahead of third-quarter pharma earnings</h3>
<p class='source-date'><em>Endpoints News • 2025-10-13</em></p>
<p>A few months of momentum have cemented hope that the worst of biotech’s bear market is in the rearview mirror, galvanizing industry insiders who have clung to cautious optimism for multiple years ...</p>
<p><a href='https://endpoints.news/three-big-questions-ahead-of-third-quarter-pharma-earnings/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>FDA on pace for lowest number of new drug approvals since 2022</h3>
<p class='source-date'><em>Endpoints News • 2025-10-13</em></p>
<p>The FDA in 2025 is set to approve its lowest number of new drug and biologic applications since 2022, even as more than a dozen companies await the regulator's decisions on their new molecular entities ...</p>
<p><a href='https://endpoints.news/fda-on-pace-for-lowest-number-of-new-drug-approvals-since-2022/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>California enacts state law building on PBM reforms</h3>
<p class='source-date'><em>Endpoints News • 2025-10-13</em></p>
<p>California Gov. Gavin Newsom signed into law what his office called a “sweeping reform” of PBM practices last week. The legislation, SB 41, prohibits spread pricing, calls for greater transparency and ...</p>
<p><a href='https://endpoints.news/california-enacts-state-law-building-on-pbm-reforms/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>FDA hands OAI classification to Novo Nordisk’s troubled Indiana site</h3>
<p class='source-date'><em>Endpoints News • 2025-10-13</em></p>
<p>The FDA issued an “official action indicated” classification to Novo Nordisk’s facility in Bloomington, IN after two biotechs received site-related complete response letters. Scholar Rock, one of the companies to face regulatory delays due to ...</p>
<p><a href='https://endpoints.news/fda-hands-oai-classification-to-novo-nordisks-troubled-indiana-site/' target='_blank'>Read more</a></p>
</div>
<h2>Microbiome & Antimicrobials News</h2>
<div class='news-item'>
<h3>October 13, 2025</h3>
<p class='source-date'><em>Microbiome Digest – Bik's Picks • 2025-10-13</em></p>
<p>General Microbiome Human microbiota research in Africa: a systematic review reveals gaps and priorities for future research – Imane Allali – Microbiome Gut microbiome Gut microbiota alterations are linked to COVID-19 severity in North African and European populations – Marius Bredon – Nature Expa...</p>
<p><a href='https://microbiomedigest.com/2025/10/13/october-13-2025/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Saccharolobus islandicus</h3>
<p class='source-date'><em>Trends in Microbiology • 2025-10-13</em></p>
<p>Saccharolobus islandicus (f. Sulfolobus islandicus) is a hyperthermophilic archaeon frequently isolated from oxic hot spring waters and sediments at 59–91°C and pH 2–4. It grows aerobically with a doubling time of 6–10 h under laboratory conditions (optimal: 76–78°C and pH 3–3.5) and forms single...</p>
<p><a href='https://www.cell.com/trends/microbiology/fulltext/S0966-842X(25)00273-2?rss=yes' target='_blank'>Read more</a></p>
</div>
<hr>
<h2>Scientific Papers</h2>
<h3>Biotech & Microbiome Focus Papers</h3>
<p>No recent papers on Biotech & Microbiome Focus available today.</p>
<h3>Synthetic & Molecular Biology Papers</h3>
<p>No recent papers on Synthetic & Molecular Biology available today.</p>
<h3>Bacteriophage Research Papers</h3>
<p>No recent papers on Bacteriophage Research available today.</p>
<h3>Skin Microbiome & Disease Papers</h3>
<div class='paper-item'>
<h4>Acetic acid produced by </h4>
<p class='source-date'><em>Lee Jae Min, Yang Hyun Oh, Tanizawa Hideki et al. | mBio • 2025-10-08</em></p>
<p><strong>Abstract:</strong> The skin microbiome is composed of diverse microbial communities that engage in interkingdom interactions, influencing host physiology and microbial balance. Although</p>
<p><a href='https://doi.org/10.1128/mbio.01592-25' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Unique genetic diversity of Propionibacterium acnes isolated from human facial skins in Thailand revealed by the multi-locus sequence typing scheme.</h4>
<p class='source-date'><em>Sripath Khemrutai, Bangperng Jaruwan, Chumnanpeun Pramote et al. | BMC microbiology • 2025-10-08</em></p>
<p><strong>Abstract:</strong> BACKGROUND/OBJECTIVE(S)/INTRODUCTION: Acne vulgaris, a prevalent dermatological concern, has shown a consistent increase in reported cases from 2016 to 2019, according to data from the Institute of Dermatology, Thailand. This condition not only causes physical and psychological discomfort but als...</p>
<p><a href='https://doi.org/10.1186/s12866-025-04183-1' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Comparison of Cutibacterium Avidum versus Acnes in Periprosthetic Hip Infections: A Matched Cohort Analysis.</h4>
<p class='source-date'><em>Mitterer J A, Kinsky R M, Frank Bjh et al. | The Journal of arthroplasty • 2025-10-08</em></p>
<p><strong>Abstract:</strong> INTRODUCTION: The precise role of Cutibacterium in periprosthetic joint infections (PJIs) and unexpected positive intraoperative cultures (UPIC) in presumed aseptic revision total hip arthroplasty (rTHA) remains unclear. Moreover, little is known about whether there are differences in prevalence,...</p>
<p><a href='https://doi.org/10.1016/j.arth.2025.09.052' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Can antimicrobial peptides provide an improved antimicrobial strategy for treatment of </h4>
<p class='source-date'><em>Bruni Gillian O | Microbiology spectrum • 2025-10-07</em></p>
<p><strong>Abstract:</strong> With increasing antibiotic resistance and the paucity of new antibiotics in the development pipeline, exploration of antimicrobial peptide applications alone or in combination with existing antibiotics is more crucial than ever. The recent study by J. Varin-Simon, E. F. Haney, M. Colin, F. Velard...</p>
<p><a href='https://doi.org/10.1128/spectrum.01785-25' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Performance and potential utility of the BioFire Joint Infection Panel with synovial fluid and joint tissue specimens.</h4>
<p class='source-date'><em>Fox-Lewis Shivani, Douglass Marc, Roberts Sally | Journal of clinical microbiology • 2025-10-08</em></p>
<p><strong>Abstract:</strong> The BioFire Joint Infection Panel (BJIP) (bioMérieux) is a rapid sample-to-answer multiplex polymerase chain reaction (PCR) platform for the diagnosis of joint infections. This retrospective study evaluated its performance with synovial fluid and joint tissue specimens from native and prosthetic ...</p>
<p><a href='https://doi.org/10.1128/jcm.00594-25' target='_blank'>View Paper</a></p>
</div>
<hr>
<p><em>Report generated on 2025-10-14</em></p>
</div>
</body>
</html>